fviii
Showing 1 - 4 of 4
Hemophilia A, Immune Tolerance Trial in Los Angeles (FVIII, Emicizumab)
Active, not recruiting
- Hemophilia A
- Immune Tolerance
- FVIII
- Emicizumab
-
Los Angeles, CaliforniaChildrens Hospital Los Angeles
Mar 7, 2022
Hemophilia A Trial in Bangkok (FVIII)
Completed
- Hemophilia A
- FVIII
-
Bangkok, Pathumwan, ThailandDivision of Hemato/oncology, Department of Pediatrics, Faculty o
Apr 1, 2016
Hemophilia A Trial in Lyon (FVIII)
Terminated
- Hemophilia A
- FVIII
-
Lyon, FranceHopital Edouard Herriot
May 13, 2013